NEW YORK — Weatherman and morning TV co-host Al Roker has revealed that he has been diagnosed with prostate cancer and will be undergoing surgery to have his prostate removed.
“It’s a good news-bad news kind of thing,” Roker said Friday on NBC’s “Today.” “Good news is we caught it early. Not great news is that it’s a little aggressive, so I’m going to be taking some time off to take care of this.”
Roker revealed he got the diagnosis Sept. 29. It began with a routine physical when his doctor discovered he had an elevated prostate-specific antigen in his blood work. That led to him getting an MRI, followed by a biopsy, to confirm his diagnosis.
The 66-year-old TV personality urged others at risk – particularly Black men – to ensure they see a doctor and get the proper checkups to stop a cancer that is very treatable if detected early.
“The problem for African Americans is that any number of reasons from genetics to access to health care, and so we want to make it available and let people know they got to get checked,” Roker said.
Roker, a father of three, was by himself when he received the diagnosis. That made his wife, ABC News correspondent Deborah Roberts, upset. “I feel badly, because I didn’t tell Deborah to come with me,” he said. “In hindsight, boy I wish I’d told her to come.”
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less